Medicare Enrolled
Dr. Katherine O'Rourke, M.D.
Dermatology · Raleigh, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. O'Rourke from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. O'Rourke?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. O'Rourke
Dr. Katherine O'Rourke is a dermatology specialist in Raleigh, NC, with 21 years of NPI registration. Based on federal Medicare data, Dr. O'Rourke performed 6,078 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. O'Rourke received a total of $16,783 from 41 pharmaceutical and/or device companies across 441 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. O'Rourke is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 16% volume in NC
$16,783 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗6,078
Medicare services
Top 16% in NC for dermatology
Not available
Unique patients (not deduplicated)
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
1,968 | $5 | $14 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,444 | $79 | $246 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
671 | $33 | $128 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
503 | $58 | $194 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
410 | $72 | $217 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
188 | $37 | $96 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
164 | $58 | $173 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
87 | $36 | $108 |
| Shaving of skin growth, 0.6-1.0 cm A minor procedure to shave off a skin growth on the body, arms, or legs that measures between 0.6 and 1.0 centimeters. |
74 | $80 | $234 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
67 | $121 | $323 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
54 | $107 | $320 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
46 | $213 | $581 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
41 | $1 | $2 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
36 | $115 | $342 |
| Shaving of skin growth, 1.1-2.0 cm This procedure involves shaving off a skin growth measuring between 1.1 and 2.0 centimeters from the body, arms, or legs. |
35 | $95 | $263 |
| Shaving of skin growth, 0.6-1.0 cm A minor procedure to shave off a skin growth measuring 0.6 to 1.0 cm from the scalp, neck, hands, feet, or genitals. |
27 | $85 | $235 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
26 | $96 | $468 |
| Topical aminolevulinic acid HCl 20% solution A topical medication applied to the skin for medical treatment. It is supplied as a single-unit dosage form containing 354 mg of the active ingredient. |
26 | $304 | $778 |
| Surgical removal of skin cancer, 2.1-3.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters. |
25 | $105 | $534 |
| Skin growth shaving, 0.5 cm or less This procedure involves shaving off a small skin growth measuring 0.5 centimeters or less from the body, arms, or legs. |
24 | $45 | $194 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
24 | $29 | $109 |
| Light therapy to destroy precancerous skin growth This procedure uses light to treat and remove precancerous skin lesions. It is a method for destroying abnormal skin cells before they become cancerous. |
24 | $99 | $264 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
23 | $55 | $185 |
| Destruction of skin growth, 15 or more growths | 22 | $86 | $254 |
| Destruction of cancerous skin growth, 2.1-3.0 cm This procedure involves the removal or destruction of a cancerous skin lesion measuring between 2.1 and 3.0 centimeters located on the trunk, arms, or legs. |
21 | $128 | $370 |
| Shaving of skin growth on face, 0.6-1.0 cm This procedure involves shaving off a skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the growth being removed is between 0.6 and 1.0 centimeters. |
20 | $98 | $263 |
| Shaving of small skin growth on face or mouth area A minor procedure to shave off a small skin growth, measuring 0.5 cm or less, located on the face, ears, eyelids, nose, lips, or mouth. |
17 | $60 | $223 |
| Shaving of skin growth, 0.5 cm or less Removal of a small skin growth by shaving it off the surface. This procedure is performed on the scalp, neck, hands, feet, or genitals. |
11 | $54 | $202 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$16,783
Total received (2018-2024)
Avg $2,398/year across 7 years
Top 11% in NC for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
441
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,422
2023
$1,571
2022
$728
2021
$288
2020
$462
2019
$1,320
2018
$9,991
Payments by company (2024)
SUN PHARMACEUTICAL INDUSTRIES INC.
$414
ABBVIE INC.
$379
Janssen Biotech, Inc.
$278
GENZYME CORPORATION
$233
Lilly USA, LLC
$151
E.R. Squibb & Sons, L.L.C.
$145
Dermavant Sciences, Inc.
$133
Regeneron Healthcare Solutions, Inc.
$127
Arcutis Biotherapeutics, Inc.
$118
Galderma Laboratories, L.P.
$84
Amgen Inc.
$82
UCB, Inc.
$61
Incyte Corporation
$55
LEO Pharma Inc.
$50
Boehringer Ingelheim Pharmaceuticals, Inc.
$44
Sandoz Inc.
$33
Tempus AI, Inc
$20
Novartis Pharmaceuticals Corporation
$17
Top 3 companies account for 44.2% of 2024 payments
All-time payments by company (2018-2024) ›
Galderma Laboratories, L.P.
$8,732
ABBVIE INC.
$850
GENZYME CORPORATION
$621
Ortho Dermatologics, a division of Bausch Health US, LLC
$513
Mayne Pharma Inc.
$489
Janssen Biotech, Inc.
$483
Amgen Inc.
$473
SUN PHARMACEUTICAL INDUSTRIES INC.
$443
Novartis Pharmaceuticals Corporation
$398
Sun Pharmaceutical Industries Inc.
$357
E.R. Squibb & Sons, L.L.C.
$320
Regeneron Healthcare Solutions, Inc.
$306
AbbVie, Inc.
$306
LEO Pharma Inc.
$298
Lilly USA, LLC
$248
Celgene Corporation
$237
UCB, Inc.
$209
Dermavant Sciences, Inc.
$192
Arcutis Biotherapeutics, Inc.
$150
Boehringer Ingelheim Pharmaceuticals, Inc.
$137
AbbVie Inc.
$134
EPI Health, LLC
$133
Incyte Corporation
$98
PFIZER INC.
$87
Mission Pharmacal Company
$81
VYNE Pharmaceuticals Inc.
$77
Mylan Pharmaceuticals Inc.
$76
Almirall LLC
$63
Biofrontera Inc.
$42
Sandoz Inc.
$33
MAYNE PHARMA INC.
$22
Surgical Specialties Corporation (US), Inc.
$20
Journey Medical Corporation
$20
Tempus AI, Inc
$20
Bayer HealthCare Pharmaceuticals Inc.
$19
TARO PHARMACEUTICALS USA, INC.
$18
STRATA Skin Sciences, Inc.
$17
Taro Pharmaceuticals USA, Inc.
$16
Aclaris Therapeutics, Inc.
$16
Genentech USA, Inc.
$16
Sebela Pharmaceuticals Inc.
$16
Top 3 companies account for 60.8% of all-time payments
Associated products mentioned in payments ›
0.25% · ABSORICA · ADBRY · AKLIEF · ALTRENO · AMELUZ · AMZEEQ · ARAZLO · Ameluz · Amnesteem · Avar · BLU-U · BOTOX · BRYHALI · Bensal HP · Bimzelx · CLODERM · COSENTYX · Cimzia · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dermatological Psoriasis and Vitiligo Treatment · EBGLYSS · EFUDEX · ENSTILAR · EPIDUO FORTE · EUCRISA · Enbrel · Finacea · HUMIRA · HYRIMOZ · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · JUBLIA · Klisyri · OLUMIANT · ONEXTON · OPZELURA · ORACEA · Odomzo · Olux · Olux-E · Otezla · PICATO · PRAMOSONE · QBREXZA · REMICADE · RHOFADE · RINVOQ · Rituxan · SILIQ · SKYRIZI · SOOLANTRA · SPEVIGO · Seysara · Sitavig · Sotyktu · Surgical wound closure product · TALTZ · TOPICORT (desoximetasone) Topical Spray · TREMFYA · ULTRAVATE · VTAMA · Winlevi · XOLAIR · ZILXI · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Dermatologists in nearby ZIP areas
116
County median income
$101,763
Nearest hospital to ZIP centroid (approximate)
REX HOSPITAL
2.6 mi
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. O'Rourke is a clinical cardiology specialist, with above-average Medicare volume (top 16% in NC), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. O'Rourke experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. O'Rourke performed 1,968 destruction of precancerous skin growths, 2-14 services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. O'Rourke receive payments from pharmaceutical companies?
Yes. Dr. O'Rourke received a total of $16,783 from 41 companies across 441 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. O'Rourke's costs compare to other dermatologists in Raleigh?
Dr. O'Rourke's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. O'Rourke) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Raleigh
Browse dermatologists in Raleigh ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in NC
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in NC
Which NC dermatologists receive the most from drug and device companies.
By company
Galderma Laboratories, L.P. Payments to Doctors
See all physicians who received payments from Galderma Laboratories, L.P.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology